News

Caydan Capital Partners News

Let's talk.

First Name
Last Name
Company
Website
Email
Phone Number
Reason for Inquiry
Additional Info
Thank you. We look forward to speaking with you.
Oops! Something went wrong while submitting the form.
close x

Caydan Capital Partners Portfolio Company MitoSense Signs Research Collaboration with University of Pittsburgh to Advance Space Biomedicine and Long COVID Research

BOSTON, MA — Caydan Capital Partners announced today that its portfolio company, MitoSense, Inc., has signed a Memorandum of Understanding (MOU) with the University of Pittsburgh to explore research opportunities at the intersection of mitochondrial biology, space biomedicine, and long COVID.

Read More

Caydan Portfolio Company MitoSense Secures Japanese Patent for Mitochondria-Based Therapy for Neurodegenerative Diseases

Plymouth, MA – Caydan Capital Partners announced today that its portfolio company, MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, has been granted a Japanese patent (Patent No. 7617652) for its innovative approach to treating neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). This milestone underscores MitoSense’s...

Read More

Caydan Portfolio Company MitoSense Secures U.S. Patent for Mitochondria-Based Therapy for Neurodegenerative Diseases

Plymouth, MA – Caydan Capital Partners announced today that its portfolio company, MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative diseases, has been issued U.S. Patent No. 12,150,958, titled “Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases, and Associated Methods...

Read More

Caydan Capital Partners Leads Venture Financing for TecTraum

BOSTON, MA — Caydan Capital Partners today announced that it has led a $965,000 venture financing for TecTraum Inc., a medical device company developing pro2cool®, a first-of-its-kind point-of-care treatment platform for concussions.

Read More

Caydan Capital Partners Appoints Naresh Shanker as Senior Advisor Caydan Ventures

BOSTON, MA — Caydan Capital Partners, a leading lower middle market private equity investment firm, announced the appointment of Naresh Shanker as Senior Advisor of Caydan Ventures, the investment firm’s early-stage venture arm. Mr. Shanker will serve as an executive resource for Caydan’s portfolio companies.

Read More

Caydan Capital Partners and Phoenix Merchant Partners Provide $13 Million Growth Financing to HCT Renewable Energy

BOSTON, MA – Caydan Capital Partners announced today that it, together with Phoenix Merchant Partners, has provided $13 million in growth financing to HCT Renewable Energy (“HCT”), a leading solar industry staffing firm. The investment capital is intended to accelerate and optimize HCT’s growth in the solar energy staffing field.

Read More

Caydan Capital Partners Leads $3.5 Million Series Seed Funding for MitoSense Inc.

PLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/—Caydan Capital Partners has led a Series Seed Funding Round for MitoSense Inc., a research and development company focused on treatments for neurodegenerative diseases. The round raised close to $3.5 million and will support MitoSense’s continued advancement of its proprietary Mitochondria Organelle Transplantation, or MOT™, technology...

Read More

Caydan Capital Partners Appoints Sam Waicberg as Managing Partner, Caydan Ventures

BOSTON, MA — Caydan Capital Partners, a leading lower middle market private equity investment firm announced the appointment of Sam Waicberg as Managing Partner, Caydan Ventures. Mr. Waicberg brings extensive executive experience to Caydan and will have a broad mandate as Managing Partner—working with Caydan’s investment teams to...

Read More

Asydan Capital Management Announces Merger with Kestrel Merchant Partners and Name Change Reflecting Firm’s Approach to Partnerships

BOSTON, MA—Asydan Capital Management, LLC, a leading lower middle market private equity firm based in Boston, Massachusetts, announced today its merger with Kestrel Merchant Partners, a respected merchant bank focused on small cap and special situations public equity. As part of the merger, Asydan will change its name to Caydan Capital Partners. 

Read More

Asydan Capital Management Exits Investment in The SAILS Group, Inc.

BOSTON, MA—Asydan* Capital Management, LLC (“Asydan”), a leading lower middle market private equity firm based in Boston, Massachusetts, announced today that it, along with Atalaya Capital Management LP (“Atalaya”), an alternative asset manager focused on private credit and special opportunities investments, has successfully exited its investment in The SAILS Group, Inc.

Read More

Private Equity

We target North American companies with strong management teams, profitable historical operating performance (generally $2M -$15M of EBITDA), and favorable market dynamics.

More Info

Venture Capital

We invest in and partner with high-potential, early-stage companies—equipping them with the resources and expertise they need to overcome challenges, and fully harness their innovative spirit for success.

More Info

Public Equity

Kestrel has two funds investing in public equity special situations.

More Info